Zobrazeno 1 - 10
of 3 247
pro vyhledávání: '"inactive kinase"'
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2009 Dec 01. 106(51), 21608-21613.
Externí odkaz:
https://www.jstor.org/stable/40536142
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dustin J. Maly, John Kuriyan, Neil P. Shah, David E. Shaw, Yibing Shan, Corynn Kasap, Pratistha Ranjitkar, Markus A. Seeliger
Supplementary Methods and Materials from Equally Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cd1ec718faf53096a6434a4c3794ee4
https://doi.org/10.1158/0008-5472.22379763
https://doi.org/10.1158/0008-5472.22379763
Autor:
Dustin J. Maly, John Kuriyan, Neil P. Shah, David E. Shaw, Yibing Shan, Corynn Kasap, Pratistha Ranjitkar, Markus A. Seeliger
Supplementary Table 1 from Equally Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0285e4fd27905ec65cfdfef8a3a7bfbe
https://doi.org/10.1158/0008-5472.22379760
https://doi.org/10.1158/0008-5472.22379760
Autor:
Dustin J. Maly, John Kuriyan, Neil P. Shah, David E. Shaw, Yibing Shan, Corynn Kasap, Pratistha Ranjitkar, Markus A. Seeliger
Supplementary Figures 1-2 from Equally Potent Inhibition of c-Src and Abl by Compounds that Recognize Inactive Kinase Conformations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cf4dcaa16b230eab2df8b5a2584d755
https://doi.org/10.1158/0008-5472.22379766.v1
https://doi.org/10.1158/0008-5472.22379766.v1
Autor:
Oguro, Yuya, Miyamoto, Naoki, Okada, Kengo, Takagi, Terufumi, Iwata, Hidehisa, Awazu, Yoshiko, Miki, Hiroshi, Hori, Akira, Kamiyama, Keiji, Imamura, Shinichi
Publikováno v:
In Bioorganic & Medicinal Chemistry 2010 18(20):7260-7273
Autor:
Dustin J. Maly, John Kuriyan, Neil P. Shah, David E. Shaw, Yibing Shan, Corynn Kasap, Pratistha Ranjitkar, Markus A. Seeliger
Imatinib is an inhibitor of the Abl tyrosine kinase domain that is effective in the treatment of chronic myelogenic leukemia. Although imatinib binds tightly to the Abl kinase domain, its affinity for the closely related kinase domain of c-Src is at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3283e1e71790727507334cd2e6fd809b
https://doi.org/10.1158/0008-5472.c.6499347.v1
https://doi.org/10.1158/0008-5472.c.6499347.v1
Autor:
Bogomolovas J; School of Medicine, University of California, San Diego, La Jolla, CA, United States., Gravenhorst P; Department of Biology, University of Konstanz, Konstanz, Germany., Mayans O; Department of Biology, University of Konstanz, Konstanz, Germany. Electronic address: olga.mayans@uni-konstanz.de.
Publikováno v:
Methods in enzymology [Methods Enzymol] 2022; Vol. 667, pp. 147-181. Date of Electronic Publication: 2022 Apr 13.
Publikováno v:
Methods in enzymology. 667
Protein pseudokinases are key regulators of the eukaryotic cell. Understanding their unconventional molecular mechanisms relies on deciphering their putative potential to perform phosphotransfer, their scaffolding properties and the nature of their r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c39a96f74164f22fbaadf360ea501c2
https://pubmed.ncbi.nlm.nih.gov/35525541
https://pubmed.ncbi.nlm.nih.gov/35525541
Publikováno v:
Methods in Enzymology ISBN: 9780323915410
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f091da006c2a8629ac088f9a7aa0f0a
https://doi.org/10.1016/bs.mie.2022.03.028
https://doi.org/10.1016/bs.mie.2022.03.028